Association Between Uric Acid Levels and Obstructive Sleep Apnea Syndrome in a Large Epidemiological Sample

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hirotsu, Camila ^a   Tufik, Sergio ^a   Guindalini, Camila ^a   Mazzotti, Diego R ^a   Bittencourt, Lia R ^a   Andersen, Monica L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

OXYHEMOGLOBIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; APNEA HYPOPNEA INDEX; AROUSAL; ARTICLE; BLOOD PRESSURE; BODY MASS; BRAZIL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OXYGEN DESATURATION; OXYGEN SATURATION; POLYSOMNOGRAPHY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; URIC ACID BLOOD LEVEL;

ADULT; BODY MASS INDEX; BRAZIL; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; HUMANS; LINEAR MODELS; MALE; ODDS RATIO; OXYHEMOGLOBINS; RISK FACTORS; ROC CURVE; SLEEP APNEA, OBSTRUCTIVE; URIC ACID;

EID: 84879476375     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066891     Document Type: Article

References (69)

1. Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR, (2010) Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 11: 441-446.
2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, et al. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328: 1230-1235.
3. Golbin JM, Somers VK, Caples SM, (2008) Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. Proc Am Thorac Soc 5: 200-206.
4. Gozal D, Kheirandish-Gozal L, (2007) Neurocognitive and behavioral morbidity in children with sleep disorders. Curr Opin Pulm Med 13: 505-509.
5. George CF, Kryger MH, (1985) Sleep and control of heart rate. Clin Chest Med 6: 595-601.
6. Guilleminault C, Connolly S, Winkle R, Melvin K, Tilkian A, (1984) Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique. Lancet 1: 126-131.
7. Sato F, Nishimura M, Shinano H, Saito H, Miyamoto K, et al. (1997) Heart rate during obstructive sleep apnea depends on individual hypoxic chemosensitivity of the carotid body. Circulation 96: 274-281.
8. Vijayan VK, (2012) Morbidities associated with obstructive sleep apnea. Expert Rev Respir Med 6: 557-566.
9. Thomas JJ, Ren J (2012) Obstructive Sleep Apnea and Cardiovascular Complications: Perception versus Knowledge. Clin Exp Pharmacol Physiol.
10. Lavie L, (2012) Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci (Elite Ed) 4: 1391-1403.
11. Sahebjani H, (1998) Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure. Chest 113: 1604-1608.
12. Saito H, Nishimura M, Shibuya E, Makita H, Tsujino I, et al. (2002) Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest 122: 1686-1694.
13. Jensen MH, Brinklov MM, Lillquist K, (1980) Urinary loss of oxypurines in hypoxic premature neonates. Biol Neonate 38: 40-48.
14. Raivio KO, (1976) Neonatal hyperuricemia. J Pediatr 88: 625-630.
15. Christensen EF, Jacobsen J, Anker-Moller E, Schultz P, Spangsberg N, (1992) Increased urinary loss of uric acid in adults with acute respiratory failure requiring mechanical ventilation. Chest 102: 556-559.
16. Grum CM, Simon RH, Dantzker DR, Fox IH, (1985) Evidence for adenosine triphosphate degradation in critically-ill patients. Chest 88: 763-767.
17. Harkness RA, Simmonds RJ, Coade SB, (1983) Purine transport and metabolism in man: the effect of exercise on concentrations of purine bases, nucleosides and nucleotides in plasma, urine, leucocytes and erythrocytes. Clin Sci (Lond) 64: 333-340.
18. Sorlie D, Myhre K, Saugstad OD, Giercksky KE, (1982) Release of hypoxanthine and phosphate from exercising human legs with and without arterial insufficiency. Acta Med Scand 211: 281-286.
19. Nagaya N, Uematsu M, Satoh T, Kyotani S, Sakamaki F, et al. (1999) Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 160: 487-492.
20. Patetsios P, Rodino W, Wisselink W, Bryan D, Kirwin JD, et al. (1996) Identification of uric acid in aortic aneurysms and atherosclerotic artery. Ann N Y Acad Sci 800: 243-245.
21. Fang J, Alderman MH, (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. Jama 283: 2404-2410.
22. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ, (2008) Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 58: 623-630.
23. Plywaczewski R, Bednarek M, Jonczak L, Gorecka D, Sliwiniski P, (2005) Hyperuricaemia in males with obstructive sleep apnoea (osa). Pneumonol Alergol Pol 73: 254-259.
24. Plywaczewski R, Bednarek M, Jonczak L, Gorecka D, Sliwinski P, (2006) Hyperuricaemia in females with obstructive sleep apnoea. Pneumonol Alergol Pol 74: 159-165.
25. Ruiz Garcia A, Sanchez Armengol A, Luque Crespo E, Garcia Aguilar D, Romero Falcon A, et al. (2006) Blood uric acid levels in patients with sleep-disordered breathing. Arch Bronconeumol 42: 492-500.
26. Puig JG, Ruilope LM, (1999) Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 17: 869-872.
27. Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc 107: 403-405.
28. Santos-Silva R, Tufik S, Conway SG, Taddei JA, Bittencourt LR, (2009) Sao Paulo Epidemiologic Sleep Study: rationale, design, sampling, and procedures. Sleep Med 10: 679-685.
29. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects: Brain Information Service/Brain Research Institute, UCLA.
30. Iber C, Ancoli-Israel S, Chesson JA, Quan S (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications: Westchester: American Academy of sleep Medicine.
31. AASM (2005) International classification of sleep disorders. Diagnostic and coding manual (ICSD-2). 2nd ed. Westchester, IL.
32. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP, (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131: 485-491.
33. Johns MW, (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14: 540-545.
34. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193-213.
35. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, et al. (1993) Development of a fatigue scale. J Psychosom Res 37: 147-153.
36. Wysocka E, Cofta S, Piorunek T, Dziegielewska-Gesiak S, Bryl W, et al. (2013) Blood antioxidant status, dysglycemia and obstructive sleep apnea. Adv Exp Med Biol 756: 121-129.
37. Schulz E, Gori T, Munzel T, (2011) Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 34: 665-673.
38. Yamazaki I, Soma T, Ichikawa Y, Iwai Y, Kondo J, et al. (1995) [Usefulness of allopurinol for prevention of myocardial reperfusion injury in open heart surgery]. Nihon Kyobu Geka Gakkai Zasshi 43: 26-31.
39. Dopp JM, Philippi NR, Marcus NJ, Olson EB, Bird CE, et al. (2011) Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats. Respiration 82: 458-467.
40. Van Hoorenbeeck K, Franckx H, Debode P, Aerts P, Wouters K, et al. (2012) Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. Obesity (Silver Spring) 20: 172-177.
41. Bergamini C, Cicoira M, Rossi A, Vassanelli C, (2009) Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 11: 444-452.
42. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM, (2006) Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37: 1503-1507.
43. Reunanen A, Takkunen H, Knekt P, Aromaa A (1982) Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl 668: 49-59.
44. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, et al. (1996) Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20: 975-980.
45. Lippi G, (2008) Relationship between uric acid, hyperglycemia and hypertriglyceridemia in general population. Biochem Med 18: 37-41.
46. Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G, et al. (2002) Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89: 12-17.
47. Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, et al. (2010) Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol 138: 206-209.
48. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, et al. (2005) Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 96: 489-495.
49. Duran M, Kalay N, Akpek M, Orscelik O, Elcik D, et al. (2012) High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology 63: 448-452.
50. Jankowska EA, Ponikowska B, Majda J, Zymlinski R, Trzaska M, et al. (2007) Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure. Int J Cardiol 115: 151-155.
51. Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, et al. (2007) Serum uric acid as an independent predictor of early death after acute stroke. Circ J 71: 1120-1127.
52. Brodov Y, Behar S, Boyko V, Chouraqui P, (2010) Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). Am J Cardiol 106: 1717-1720.
53. Jubber AS, (2004) Respiratory complications of obesity. Int J Clin Pract 58: 573-580.
54. Verhulst SL, Van Hoeck K, Schrauwen N, Haentjens D, Rooman R, et al. (2007) Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. Chest 132: 76-80.
55. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, et al. (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. Jama 283: 1829-1836.
56. Peppard PE, Young T, Palta M, Skatrud J, (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342: 1378-1384.
57. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, et al. (2004) Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4: 9.
58. Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, et al. (2004) Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 27: 227-233.
59. Desai MY, Santos RD, Dalal D, Carvalho JA, Martin DR, et al. (2005) Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men. Am J Cardiol 95: 865-868.
60. Drager LF, Lopes HF, Maki-Nunes C, Trombetta IC, Toschi-Dias E, et al. (2010) The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 5: e12065.
61. Liu W, Ge R, Mei X, He T, Zhang Q, et al. (2010) [Effect of obstructive sleep apnea- hypopnea syndrome on hypertension and metabolism disorder]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24: 1074-1076.
62. Kaditis A, Gozal D, Snow AB, Kheirandish-Gozal L, Alexopoulos E, et al. (2010) Uric acid excretion in North American and Southeast European children with obstructive sleep apnea. Sleep Med 11: 489-493.
63. Hira HS, Shukla A, Kaur A, Kapoor S, (2012) Serum uric acid and lactate levels among patients with obstructive sleep apnea syndrome: which is a better marker of hypoxemia? Ann Saudi Med 32: 37-42.
64. Steiropoulos P, Kotsianidis I, Nena E, Tsara V, Gounari E, et al. (2009) Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep 32: 537-543.
65. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, et al. (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107: 1991-1997.
66. Shimizu Y, Nagaya N, Satoh T, Uematsu M, Kyotani S, et al. (2002) Serum uric acid level increases in proportion to the severity of pulmonary thromboembolism. Circ J 66: 571-575.
67. Garcia-Pachon E, Padilla-Navas I, Shum C, (2007) Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease. Lung 185: 21-24.
68. Braghiroli A, Sacco C, Erbetta M, Ruga V, Donner CF, (1993) Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 148: 173-178.
69. McKeon JL, Saunders NA, Murree-Allen K, Olson LG, Gyulay S, et al. (1990) Urinary uric acid:creatinine ratio, serum erythropoietin, and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea. Am Rev Respir Dis 142: 8-13.